Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaqing Ding

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Acta Biomaterialia|December 20, 2024
A GSH-responsive oxidative stress nanoamplifier for self-augmented chemo/chemodynamic therapy to reverse cisplatin resistanceYanjuan Huang, Meng Xia, Congjun Xu, et al.
Angewandte Chemie (International Ed. in English)|May 5, 2022
A Stimuli-Responsive Small-Molecule Metal-Carrying Prochelator: A Novel Prodrug Design Strategy for Metal ComplexesZeqian Huang, Yong Luo, Tao Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2021
Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapyMeixu Chen, Zeqian Huang, Meng Xia, et al.
Acta Biomaterialia|August 16, 2024
A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imagingYaqing Ding, Zeqian Huang, Yong Luo, et al.
Cancer Letters|May 25, 2026
Pharmacological Induction of Mitochondria-Lysosome Hyper-Tethering Elicits Synthetic Lethality in GlioblastomaDongyuan Su, Yanping Huang, Biao Hong, et al.
Theranostics|December 22, 2025
LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastomaQi Zhan, Kaikai Yi, Shixue Yang, et al.
Cancer Letters|April 3, 2025
ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathwayChunchao Cheng, Longtao Cui, Xiaoteng Cui, et al.
Neuro-Oncology|December 31, 2025
VITA-GBM: EPIC-0502-Driven HIF1α Degradation Overcomes Bevacizumab Resistance and Synergizes with TMZ in GlioblastomaYaqing Ding, Qi Zhan, Longtao Cui, et al.
Neuro-Oncology|August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastomaBiao Hong, Eryan Yang, Dongyuan Su, et al.
Neuro-Oncology|April 22, 2026
NEU1 Sustains Mitochondria-Lysosome Contacts to Trigger Lysosomal Cu²⁺/Cathepsin Escape and Mitochondrial lysis in Glioblastoma (NeuLysis)Yanping Huang, Dongyuan Su, Xiaoteng Cui, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Biomaterialia|December 20, 2024
A GSH-responsive oxidative stress nanoamplifier for self-augmented chemo/chemodynamic therapy to reverse cisplatin resistanceYanjuan Huang, Meng Xia, Congjun Xu, et al.
Angewandte Chemie (International Ed. in English)|May 5, 2022
A Stimuli-Responsive Small-Molecule Metal-Carrying Prochelator: A Novel Prodrug Design Strategy for Metal ComplexesZeqian Huang, Yong Luo, Tao Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2021
Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapyMeixu Chen, Zeqian Huang, Meng Xia, et al.
Acta Biomaterialia|August 16, 2024
A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imagingYaqing Ding, Zeqian Huang, Yong Luo, et al.
Cancer Letters|May 25, 2026
Pharmacological Induction of Mitochondria-Lysosome Hyper-Tethering Elicits Synthetic Lethality in GlioblastomaDongyuan Su, Yanping Huang, Biao Hong, et al.
Theranostics|December 22, 2025
LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastomaQi Zhan, Kaikai Yi, Shixue Yang, et al.
Cancer Letters|April 3, 2025
ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathwayChunchao Cheng, Longtao Cui, Xiaoteng Cui, et al.
Neuro-Oncology|December 31, 2025
VITA-GBM: EPIC-0502-Driven HIF1α Degradation Overcomes Bevacizumab Resistance and Synergizes with TMZ in GlioblastomaYaqing Ding, Qi Zhan, Longtao Cui, et al.
Neuro-Oncology|August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastomaBiao Hong, Eryan Yang, Dongyuan Su, et al.
Neuro-Oncology|April 22, 2026
NEU1 Sustains Mitochondria-Lysosome Contacts to Trigger Lysosomal Cu²⁺/Cathepsin Escape and Mitochondrial lysis in Glioblastoma (NeuLysis)Yanping Huang, Dongyuan Su, Xiaoteng Cui, et al.
Pageof 3